UnitedHealth Group stock has a bearish daily setup, despite a positive MACD histogram on the 15-minute chart. The hourly structure supports the daily view. Oversold readings complicate short-term timing, but they do not establish a bullish case.
Key takeaways
UnitedHealth Group stock closed Wednesday at $349.91, falling 10.21% versus the previous close on volume of 17,360,600 shares.
Daily RSI14 is 28.48, in oversold territory, while the daily MACD line is -2.63, below its signal at 2.
The close sits below the daily 20-session EMA at $397.03, the 50-session EMA at $396.2 and the 200-session EMA at $381.2.
Hourly RSI14 is 19.16 and the 15-minute RSI14 is 30.52, both below 50.
For the next session, the daily pivot is $359.97, with first resistance at $377.47 and first support at $332.4.
On Wednesday, November 18, 2026, UnitedHealth Group opened at $387.14, traded between a low of $342.46 and a high of $387.53, and closed at $349.91, against a previous close of $389.68. The stock fell 10.21% versus the previous close, with volume of 17,360,600 shares.
Meanwhile, reports published during Wednesday’s session linked UnitedHealth’s decline to a proposed anti-fraud rule from the Centers for Medicare & Medicaid Services. The proposal would toughen oversight of Medicare, Medicaid, the Children’s Health Insurance Program and the health insurance marketplace. It remains a proposal, rather than a completed regulatory change.
UnitedHealth Group stock: the daily chart sets a bearish bias
The daily chart maintains a bearish bias. These averages form overhead reference levels, although their ordering is not a fully bearish stack.
Notably, daily RSI14 stands at 28.48, in oversold territory. The daily MACD line is -2.63, below its signal at 2, with a negative histogram of -4.63. That combination leaves the daily momentum evidence bearish despite the oversold RSI.
The close is also below the daily lower Bollinger band at $374.05, with the mid-band at $403.16. Price is therefore outside the lower band, not merely below the central average. Daily ATR14 rose to $14.16 from $11.62, indicating greater absolute volatility than in the preceding daily reading.
Hourly confirmation, with a short-term conflict
The hourly chart confirms the bearish bias, while the 15-minute chart offers a short-term conflict. The hourly averages are bearishly aligned. The close is below the 20-hour EMA at $377.09, followed by $390.52 and $394.08 for the 50- and 200-hour EMAs. The hourly structure therefore confirms the daily bias.
Hourly RSI14 is 19.16, also oversold. The hourly MACD line at -14.45 remains below its signal at -9.51, with a histogram of -4.94. The close sits above the hourly lower Bollinger band at $338.28 but below its mid-band at $385.59.
In contrast, the 15-minute MACD line at -7.96 is above its signal at -8.95, producing a positive histogram of 0.99. That is the clearest counterweight to the broader bearish evidence. However, 15-minute RSI14 is 30.52, below 50, while the close remains below the 20-quarter-hour EMA at $355.65. The 15-minute Bollinger mid-band at $353.77 is also overhead, limiting this chart’s role to execution context.
Next-session levels and conditional scenarios
For the next session, the key reference is the daily pivot at $359.97, with first resistance at $377.47 and first support at $332.4. The hourly pivot is $349.53, with first resistance at $351.85 and first support at $347.58. The 15-minute pivot is $349.87, with first resistance at $351.51 and first support at $348.25. These are reference levels for when trading resumes.
A bullish scenario requires UnitedHealth Group stock to clear the 15-minute first resistance at $351.51, then the hourly first resistance at $351.85. Reclaiming the 15-minute mid-band at $353.77 and its 20-quarter-hour EMA at $355.65 would add support. A move above the daily pivot at $359.97 would strengthen that case. The daily lower band at $374.05 is the next broader reference.
Conversely, a break below the 15-minute first support at $348.25 and hourly first support at $347.58 would undermine that bullish scenario. Below the session low at $342.46, the hourly lower band at $338.28 precedes daily first support at $332.4.
Overall, the $349.91 close stands above the short-term pivots but below the daily pivot and all cited averages. Daily ATR documents greater volatility, while oversold readings and the positive 15-minute histogram leave short-term direction uncertain. The daily bearish structure remains the controlling evidence.
FAQ
What does the daily chart show for UnitedHealth Group stock?
The close sits below the daily 20-session EMA at $397.03, the 50-session EMA at $396.2 and the 200-session EMA at $381.2. Daily RSI14 is 28.48, in oversold territory. The daily MACD line is -2.63, below its signal at 2, with a histogram of -4.63.
What are the key levels for the next session?
The daily pivot is $359.97, with first resistance at $377.47 and first support at $332.4. The hourly pivot stands at $349.53, with first resistance at $351.85 and first support at $347.58. The 15-minute pivot is $349.87, with first resistance at $351.51 and first support at $348.25.
Do the oversold readings establish a bullish case?
No. Oversold readings complicate short-term timing, but they do not establish a bullish case. The daily bearish structure remains the controlling evidence.
What is the short-term conflict on the 15-minute chart?
The 15-minute MACD line at -7.96 is above its signal at -8.95, producing a positive histogram of 0.99. However, 15-minute RSI14 is 30.52, below 50, while the close remains below the 20-quarter-hour EMA at $355.65.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument. The analysis provided is not indicative of future results. Investing in financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Cryptonomist and the author hold no positions in the financial instruments mentioned and receive no compensation from the companies covered.
Read also: UnitedHealth Stock Stalls Near $377 as Lawsuit Risk Returns
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.
